Evaluation of a New Antibody-Based NT-proBNP Assay for Acute Dyspnea in the Emergency Department
The new Access NT-proBNP assay provides strong diagnostic and prognostic performance in ED patients with suspected acute HF, with results comparable to a reference NT-proBNP assay.
Authors
- Jessica Guidi
- Brandon R. Allen (ORCID: https://orcid.org/0000-0003-2577-016X)
- Dileepa Alahapperuma
- Elizabeth Walters (ORCID: https://orcid.org/0000-0001-7827-0228)
- C. Mary Healy
- Nicole Winden
- Sean P. Collins
- James L Januzzi
- Robert H Christenson
- W Franklin Peacock
Institutions
- University of Maryland, Baltimore (US)
- Harvard University (US)
- Medical University of South Carolina (US)
- Baylor College of Medicine (US)
- Loma Linda University (US)
- Brown University (US)
- University of Florida Health (US)
- University of Florida (US)
- Massachusetts General Hospital (US)
- VA Tennessee Valley Healthcare System (US)
- Geriatric Research Education and Clinical Center (US)
- Baim Institute for Clinical Research (US)
- Beckman Coulter Foundation (US)
Publication Details
- Journal
- Clinical Chemistry
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1093/clinchem/hvaf168
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00